Table 1. Oligonucleotides used in this study.

Primer name	Sequence	Restriction site
Pf-1	5′-GCGCAGATCTAAACGAATATTCAGGTTGG-3′	BglII
Pf-2	5′-GCGCCTCGAGCTACCAAATATGATTTTGAAATTTGGG-3′	XhoI
Pf-3	5′-GCGCAGATCTGGAGAAATAACCGATCTATAATTATAGG-3′	BglII
Pf-4	5′-GCGCCTCGAGCTAAAGTTCTTGTAATATCCATGAACG-3′	XhoI
Pb-1	5′-GCGCAGATCTATGCCAGGTATATCCTGTTTTGTAAAACGATGTTATGG-3′	BglII
Pb-2	5′-GCGCGCGGCCGCTTAGAGTTCTTCTAATATCCATGAAGTTATTTCTTCTAAGG-3′	NotI
Pb-3	5′-GCGCGGATCCCAAAATATTTACTTTAATTTATCGTTGG-3′	BamHI
Pb-4	5′-GCGCCCGCGGTTAGTCTAATGCATCTGAAAAAACATTTCC-3′	SacII
Pb-5	5′-GCGCCCGCGGGGACAAGCATAGCTTATGCCCGATC-3′	SacII
Pb-6	5′-GCGCGGTACCTACATTATATTTAATATATAACAGGG-3′	KpnI
Pb-7	5′-GCGCAAGCTTCCAACGATAAATTAAAGTAAATATTTTG-3′	HindIII
Pb-8	5′-GCGCGCGGCCGCCCAATACTTTAAAACATTTAACAATC-3′	NotI
Pb-9	5′-GCGCCCGCGGGGACAAGCATAGCTTATGCCCGATC-3′	SacII
Pb-10	5′-GGATAATGTAATAAAATCTAGCCATTTAACTC-3′
Pb-11	5′-GCGCGTGTTGGTGTGTATATGAGAAATTCC-3′
Pb-12	5′-GTGTTGGTGTGTATATGAGAAATTCC-3′
b3D-1	5′-CCCGCACGGACGAATCCAGATGG-3′
b3D-2	5′-GCGCCGACGTTGTAAAACGACGGCC-3′
b3D-3	5′-CGCATTATATGAGTTCATTTTACACAATCC-3′